Ascend Wellness Holdings Inc. (CSE: AAWH.U) (OTCQX: AAWH) reported mixed second-quarter results on Monday, with revenue growth offset by declining profits amid more competition in some markets. The New York-based multistate operator posted revenue of $141.5 million for the quarter ending June 30, up 15% from a year earlier. However, …
Incannex Healthcare gets FDA nod for Phase 2 trial
Incannex Healthcare Inc. (Nasdaq: IXHL) has received approval from the US Food and Drug Administration (FDA) to begin its Phase 2 clinical trial studying psilocybin on patients with generalized anxiety disorder (GAD). The trial uses Incannex’s psilocybin compound known as PSX-001. The psilocybin treatment is also accompanied by psychotherapy. Incannex …
Survey: New York’s cannabis market suffering from supply chain crunch
A recent survey by the Cannabis Association of New York (CANY) shows widespread supply chain issues in the state’s fledgling cannabis industry, even as most operators surveyed remain optimistic about sales prospects in the coming months. In the survey, conducted in late June, 78% of dispensary owners said that their …
Leef revenue slips, but losses and expenses drop dramatically
After the markets closed on Thursday, LEEF Brands Inc. (CSE: LEEF) (OTC: LEEEF) reported that its revenue fell to $7.9 million for the quarter ending June 30, versus last year’s $9.2 million for the same period. In the same period, Leef also cut losses significantly to $3.9 million, versus last …